Articles March/April 2025

REVIEW ARTICLES

HOW FIRST-LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS

Yasmine Houbaida, Maria Livia Del Giudice, Sara Galimberti, Gabriele Buda

Page e2025026   PDF         HTML        DOI: https://doi.org/10.4084/MJHID.2025.026

 

HOW FIRST-LINE THERAPY IS CHANGING IN NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS.

Fazio F., Deiana L., Loi C., Mura F., Petrucci M.T., Derudas  D.

Page e2025025     PDF           HTML   DOI: https://doi.org/10.4084/MJHID.2025.025

 

NOVELTIES ON MULTIPLE MYELOMA FROM THE MAIN 2024 HEMATOLOGY CONFERENCES

Sonia Morè, Laura Corvatta, Valentina Maria Manieri, Erika Morsia, Antonella Poloni, Massimo Offidani

Page e2025027     PDF          HTML         DOI: https://doi.org/10.4084/MJHID.2025.027

 

WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 2- FOCUS ON THERAPY

Michele Bibas, Shayna Sarosiek , Jorge Castillo

Page e2025015      PDF       HTML       DOI: https://doi.org/10.4084/MJHID.2025.015

 

ORIGINAL ARTICLES

GREEK CONSENSUS ON CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATMENT

Sotirios Sachanas, Theodoros Vassilakopoulos, Maria Angelopoulou, sotirios Papageorgiou, Emmanouil Spanoudakis, Maria Bouzani, Maria Dimou, Panagiotis Panagiotidis

Page e2025014       PDF        HTML     DOI: https://doi.org/10.4084/MJHID.2025.014

 

T-CELL RECEPTOR (TCR)-VΒ REPERTOIRE FLOW CYTOMETRY FOR T-CELL LYMPHOPROLIFERATIVE DISORDER: A RETROSPECTIVE ANALYSIS OF A SINGLE-CENTER REAL-LIFE LABORATORY EXPERIENCE

Marco Antonacci, Jacopo Micozzi, Alessandro Costa, Alessandro Laganà, Maria Laura Milani, Stefania Intoppa, Vittorio Bellomarino, Maria Grazia Nardacci, Mario Biglietto, Stefano Imperatore, Maria Laura Bisegna, Maurizio Martelli, Irene Della Starza, Maria Stefania De Propris

Page e2025016   PDF Suppl. Files  HTML   PDF   DOI: https://doi.org/10.4084/MJHID.2025.016

 

GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE

Lang Peng, Lixin Zou, Xiaoliu Liu

Page e2025012    PDF    PDF Suppl. Files   HTML DOI: https://doi.org/10.4084/MJHID.2025.012

 

Case Reports

Leukemia cutis in a patient with acute myeloid leukemia undergoing Azacitidine-Venetoclax: case presentation and review of the literature

Elisa Buzzatti, Cristina Mauro, Caterina Botti, Roberta Presicci, Giovangiacinto Paterno, Raffaele Palmieri, Carmelo Gurnari, Flavia Mallegni, Elisa Meddi, Federico Moretti, Lucia Cardillo, Valeria Mezzanotte, Kristian Taka, Lucrezia De Marchi, Luca Maurillo, Francesco Buccisano, Adriano Venditti, Maria Ilaria Del Principe

Page e2025013    PDF     HTML   DOI: https://doi.org/10.4084/MJHID.2025.013

 

 

Scientific Letters

Risk Factors of Hepatitis B Virus Infection in the Kurdistan Region of Iraq: A Cross-Sectional Study

Nawfal R Hussein, Halder J Abozait, Ibrahim A Naqid, Nashwan MR Ibrahim, Fatima K Khalid, Dildar H Musa, Zana SM Saleem

Page e2025018   PDF     HTML

 

 

Letters to the Editor

COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon in a patient with monoclonal gammopathy of undetermined significance

Kun Yang

Page e2025024    PDF      HTML   DOI: https://doi.org/10.4084/MJHID.2025.024

 

Successful Management of Steroid-Resistant cutaneous Acute Graft-versus-Host Disease, Toxic Epidermal Necrolysis-Like, with Ruxolitinib

Fahir Ozturk, Mehmet Sezgin Pepeler, Esra Ucaryilmaz Ozhamam, Gulten Korkmaz

Page e2025020  PDF         HTML  DOI: https://doi.org/10.4084/MJHID.2025.020

 

Is laboratory monitoring useful in DOACs management?

Mario Biglietto, Rosaria Mormile, Matteo Totaro, Maria Laura Bisegna, Cristina Santoro, Antonio Chistolini

Page e2025019  PDF             HTML    DOI: https://doi.org/10.4084/MJHID.2025.019

 

Genetically Predicted Antibody Levels as a Proxy for Helicobacter pylori Infection

Nawfal R Hussein

Page e2025021   PDF    HTML   DOI: https://doi.org/10.4084/MJHID.2025.021

 

The Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib.

Katia Paciaroni, Selenia Campagna, Nicoletta Villiva', Enrico Maffini, Francesca Celesti, Attilio Tordi, Mariangela Lombardi, Giulia Dragonetti, Tommaso Caravita di Toritto

Page e2025023   PDF     HTML   DOI: https://doi.org/10.4084/MJHID.2025.023

 

Direct oral anticoagulants (DOACs) in the onco-hematologic patients

Mario Biglietto, Silvio Ligia, Alessandro Laganà, Giovanni Manfredi Assanto, Martina Gherardini, Erminia Baldacci, Cristina Santoro, Antonio Chistolini

Page e2025022   PDF      HTML    DOI: https://doi.org/10.4084/MJHID.2025.022

 

Clinical Manifestation of Children with Kawasaki Disease during the COVID-19 Pandemic in Iran: A Case Series

Zahra Fotokian

Page e2025017    PDF    HTML      DOI: https://doi.org/10.4084/MJHID.2025.017